Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | increases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Demecolcine results in increased expression of ANKRD10 mRNA | CTD | PMID:23649840 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | ANKRD10 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ANKRD10 mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | ISO | Ankrd10 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ANKRD10 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | multiple interactions | ISO | Ankrd10 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ANKRD10 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | multiple interactions | ISO | Ankrd10 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ANKRD10 mRNA | CTD | PMID:17942748 | 17beta-estradiol | decreases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of ANKRD10 mRNA | CTD | PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Ankrd10 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ANKRD10 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ANKRD10 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Ankrd10 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ANKRD10 mRNA | CTD | PMID:19770486 and PMID:25270620 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ankrd10 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ANKRD10 mRNA | CTD | PMID:21570461 | 5-aza-2'-deoxycytidine | multiple interactions | ISO | ANKRD10 (Homo sapiens) | 6480464 | Decitabine inhibits the reaction [Smoke results in decreased expression of ANKRD10 mRNA] | CTD | PMID:21095227 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of ANKRD10 mRNA | CTD | PMID:30047161 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of ANKRD10 mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases expression | ISO | Ankrd10 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of ANKRD10 mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | increases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of ANKRD10 mRNA | CTD | PMID:33167477 | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of ANKRD10 mRNA | CTD | PMID:30047161 | arsane | affects expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Arsenic affects the expression of ANKRD10 mRNA | CTD | PMID:18414638 | arsenic atom | affects expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Arsenic affects the expression of ANKRD10 mRNA | CTD | PMID:18414638 | benzo[a]pyrene | increases expression | ISO | Ankrd10 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of ANKRD10 mRNA | CTD | PMID:19770486 and PMID:22228805 | benzo[a]pyrene | increases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of ANKRD10 mRNA | CTD | PMID:20106945 and PMID:21632981 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20018196 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ANKRD10 mRNA | CTD | PMID:25181051 more ... | bisphenol A | increases methylation | ISO | ANKRD10 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of ANKRD10 gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | Ankrd10 (Mus musculus) | 6480464 | bisphenol A results in increased expression of ANKRD10 mRNA | CTD | PMID:33221593 | bisphenol A | multiple interactions | ISO | ANKRD10 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of ANKRD10 gene | CTD | PMID:31601247 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of ANKRD10 gene | CTD | PMID:28505145 | butanal | decreases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of ANKRD10 mRNA | CTD | PMID:26079696 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of ANKRD10 mRNA | CTD | PMID:33453195 | carbamazepine | affects expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of ANKRD10 mRNA | CTD | PMID:25979313 | chlorpyrifos | increases expression | ISO | Ankrd10 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of ANKRD10 mRNA | CTD | PMID:37019170 | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of ANKRD10 mRNA | CTD | PMID:30556269 | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of ANKRD10 mRNA | CTD | PMID:30556269 | crocidolite asbestos | increases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Asbestos and Crocidolite results in increased expression of ANKRD10 mRNA | CTD | PMID:18687144 | crotonaldehyde | decreases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | 2-butenal results in decreased expression of ANKRD10 mRNA | CTD | PMID:20471460 | cyclosporin A | decreases expression | ISO | Ankrd10 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of ANKRD10 mRNA | CTD | PMID:19770486 | cyclosporin A | decreases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of ANKRD10 mRNA | CTD | PMID:25562108 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of ANKRD10 mRNA | CTD | PMID:21266533 | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ANKRD10 mRNA | CTD | PMID:33729688 | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of ANKRD10 mRNA | CTD | PMID:21551480 | doxorubicin | increases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of ANKRD10 mRNA | CTD | PMID:29803840 | entinostat | decreases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | entinostat results in decreased expression of ANKRD10 mRNA | CTD | PMID:27188386 | etoposide | decreases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Etoposide results in decreased expression of ANKRD10 mRNA | CTD | PMID:21527772 | flusilazole | affects expression | ISO | Ankrd10 (Mus musculus) | 6480464 | flusilazole affects the expression of ANKRD10 mRNA | CTD | PMID:21195148 | folic acid | multiple interactions | ISO | Ankrd10 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ANKRD10 mRNA | CTD | PMID:22206623 | fulvestrant | multiple interactions | ISO | ANKRD10 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of ANKRD10 gene | CTD | PMID:31601247 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of ANKRD10 mRNA | CTD | PMID:27387713 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of ANKRD10 mRNA | CTD | PMID:22061828 | hexaconazole | affects expression | ISO | Ankrd10 (Mus musculus) | 6480464 | hexaconazole affects the expression of ANKRD10 mRNA | CTD | PMID:21195148 | leflunomide | decreases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of ANKRD10 mRNA | CTD | PMID:28988120 | melphalan | increases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Melphalan results in increased expression of ANKRD10 mRNA | CTD | PMID:22363485 | mercury dichloride | decreases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Mercuric Chloride results in decreased expression of ANKRD10 mRNA | CTD | PMID:27188386 | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of ANKRD10 mRNA | CTD | PMID:30047161 | methotrexate | affects expression | ISO | Ankrd10 (Mus musculus) | 6480464 | Methotrexate affects the expression of ANKRD10 mRNA | CTD | PMID:18502557 | methylmercury chloride | increases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of ANKRD10 mRNA | CTD | PMID:23179753 more ... | miconazole | decreases expression | ISO | Ankrd10 (Mus musculus) | 6480464 | Miconazole results in decreased expression of ANKRD10 mRNA | CTD | PMID:27462272 | mifepristone | increases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Mifepristone results in increased expression of ANKRD10 mRNA | CTD | PMID:17584828 | mono(2-ethyl-5-oxohexyl) phthalate | affects expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | mono(2-ethyl-5-oxohexyl)phthalate affects the expression of ANKRD10 mRNA | CTD | PMID:34478338 | N-methyl-4-phenylpyridinium | decreases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of ANKRD10 mRNA | CTD | PMID:24810058 | N-methylformamide | decreases expression | ISO | Ankrd10 (Mus musculus) | 6480464 | methylformamide analog results in decreased expression of ANKRD10 mRNA and methylformamide results in decreased expression of ANKRD10 mRNA | CTD | PMID:17040096 | ozone | multiple interactions | ISO | Ankrd10 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ANKRD10 mRNA | CTD | PMID:34911549 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ANKRD10 mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ankrd10 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ANKRD10 mRNA | CTD | PMID:36331819 | phenobarbital | affects expression | ISO | Ankrd10 (Mus musculus) | 6480464 | Phenobarbital affects the expression of ANKRD10 mRNA | CTD | PMID:23091169 | picoxystrobin | decreases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | picoxystrobin results in decreased expression of ANKRD10 mRNA | CTD | PMID:33512557 | pirinixic acid | multiple interactions | ISO | Ankrd10 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ANKRD10 mRNA | CTD | PMID:19710929 | pirinixic acid | decreases expression | ISO | Ankrd10 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of ANKRD10 mRNA | CTD | PMID:18445702 | potassium chromate | increases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of ANKRD10 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | ANKRD10 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ANKRD10 mRNA | CTD | PMID:22079256 | quercetin | increases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Quercetin results in increased expression of ANKRD10 mRNA | CTD | PMID:21632981 | resveratrol | multiple interactions | ISO | ANKRD10 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of ANKRD10 mRNA | CTD | PMID:23557933 | silicon dioxide | decreases expression | ISO | Ankrd10 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of ANKRD10 mRNA | CTD | PMID:19073995 | sodium arsenate | decreases expression | ISO | Ankrd10 (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of ANKRD10 mRNA | CTD | PMID:21795629 | sodium arsenite | increases expression | ISO | Ankrd10 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of ANKRD10 mRNA | CTD | PMID:36209798 | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of ANKRD10 mRNA | CTD | PMID:30047161 | temozolomide | decreases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of ANKRD10 mRNA | CTD | PMID:31758290 | tert-butyl hydroperoxide | decreases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of ANKRD10 mRNA | CTD | PMID:15336504 | thapsigargin | increases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Thapsigargin results in increased expression of ANKRD10 mRNA | CTD | PMID:29453283 | thimerosal | increases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Thimerosal results in increased expression of ANKRD10 mRNA | CTD | PMID:27188386 | topotecan | affects response to substance | ISO | ANKRD10 (Homo sapiens) | 6480464 | ANKRD10 protein affects the susceptibility to Topotecan | CTD | PMID:16217747 | triadimefon | affects expression | ISO | Ankrd10 (Mus musculus) | 6480464 | triadimefon affects the expression of ANKRD10 mRNA | CTD | PMID:21195148 | Tributyltin oxide | decreases expression | ISO | Ankrd10 (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in decreased expression of ANKRD10 mRNA | CTD | PMID:25270620 | tungsten | increases expression | ISO | Ankrd10 (Mus musculus) | 6480464 | Tungsten results in increased expression of ANKRD10 mRNA | CTD | PMID:30912803 | urethane | increases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Urethane results in increased expression of ANKRD10 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ANKRD10 mRNA | CTD | PMID:25979313 | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of ANKRD10 mRNA | CTD | PMID:29427782 | valproic acid | decreases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ANKRD10 mRNA | CTD | PMID:23179753 more ... | valproic acid | increases methylation | ISO | ANKRD10 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of ANKRD10 gene | CTD | PMID:29154799 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of ANKRD10 mRNA | CTD | PMID:23869203 | zoledronic acid | increases expression | ISO | ANKRD10 (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of ANKRD10 mRNA | CTD | PMID:20977926 | |